1. Home
  2. UPBD vs JANX Comparison

UPBD vs JANX Comparison

Compare UPBD & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Upbound Group Inc.

UPBD

Upbound Group Inc.

N/A

Current Price

$15.81

Market Cap

1.1B

ML Signal

N/A

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

N/A

Current Price

$16.52

Market Cap

975.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UPBD
JANX
Founded
1986
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
975.7M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
UPBD
JANX
Price
$15.81
$16.52
Analyst Decision
Strong Buy
Buy
Analyst Count
4
13
Target Price
$32.25
★ $47.00
AVG Volume (30 Days)
784.7K
★ 833.6K
Earning Date
04-30-2026
05-08-2026
Dividend Yield
★ 8.25%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.98
N/A
Revenue
★ $4,695,061,000.00
$10,000,000.00
Revenue This Year
$5.96
N/A
Revenue Next Year
$6.47
N/A
P/E Ratio
$16.11
★ N/A
Revenue Growth
★ 8.67
N/A
52 Week Low
$15.37
$12.12
52 Week High
$23.98
$35.34

Technical Indicators

Market Signals
Indicator
UPBD
JANX
Relative Strength Index (RSI) 25.65 45.11
Support Level N/A $15.75
Resistance Level $19.67 $16.68
Average True Range (ATR) 0.49 0.75
MACD -0.15 -0.17
Stochastic Oscillator 14.33 24.16

Price Performance

Historical Comparison
UPBD
JANX

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has four operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions, Mexico segment offers lease-to-own stores in Mexico. The The Brigit segment offers various financial health products and tools to help users improve their financial health. The company derives a majority of its revenue from the Acima segment.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Share on Social Networks: